Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
5
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
5
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
ipo
novartis
pfizer
deals
gene therapy
johnson & johnson
medicare
aldeyra therapeutics
alzheimer's disease
amgen
bristol-myers squibb
What
bio
5
×
roundup
alzheimer’s
billions
drug
gene
news
aducanumab
allogene
amyloid
angst
august
bagged
becker
biogen
biogen’s
biotech
brammer
busy
cancer
companies
crispr
days
decisions
devices
different
diversity
dollars
drugs
eaton
effects
fail
failure
fda
felt
healthcare
hot
immunotherapy
impact
increases
Language
unset
Current search:
celgene
×
bio
×
biogen
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More